文献速递妇科

宫颈与子宫内膜恶性肿瘤腹腔镜前哨淋巴结示踪:两种近红外荧光系统的病例对照研究

Laparoscopic Sentinel Node Mapping in Cervical and Endometrial Malignancies: A Case-Control Study Comparing Two Near-Infrared Fluorescence Systems.
PubMed 文献 · J Minim Invasive Gynecol · 2017-08-12

在意大利圣杰拉尔多医院妇科肿瘤手术单元,2016年10月至2017年5月连续纳入34例早期宫颈癌(IA1-IB1期)或局限期子宫内膜癌患者,行腹腔镜吲哚菁绿前哨淋巴结示踪。22例使用Storz 1S系统(A组),12例使用Novadaq PinPoint系统(B组)。B组示踪时间较A组缩短(p=.0003),两组前哨淋巴结检出数、双侧检出率等无显著差异;两种系统均有效,PinPoint系统似更便于术者快速识别前哨淋巴结。

要点

  • B组前哨淋巴结示踪时间较A组缩短(p=.0003)。
  • 两组前哨淋巴结检出数中位数均为2枚(p=.501)。
  • 双侧示踪率A组77.3% vs B组83.3%(p=.334)。

核心结论

  • 两种荧光系统均适用于早期宫颈癌或子宫内膜癌的前哨淋巴结检测,PinPoint系统似更便于术者快速识别前哨淋巴结,尤其在子宫内膜癌患者中。

研究设计与样本

  • 病例对照研究(加拿大工作组分类II-2),在意大利圣杰拉尔多医院妇科肿瘤手术单元开展。
  • 2016年10月至2017年5月连续纳入34例早期宫颈癌(IA1-IB1期)或局限期子宫内膜癌患者,均行腹腔镜吲哚菁绿前哨淋巴结示踪。
  • A组22例使用Storz 1S系统(Karl Storz Endoscopy,德国图特林根),B组12例使用Novadaq PinPoint系统(Novadaq,加拿大安大略省米西索加)。

主要发现

  • B组前哨淋巴结示踪时间较A组缩短(p=.0003)。
  • 前哨淋巴结切除数中位数A组2枚(范围0-5)vs B组2枚(范围1-3)(p=.501)。
  • 双侧示踪率A组77.3% vs B组83.3%(p=.334)。
  • 体质指数、住院时间、肿瘤类型、双侧示踪及淋巴结切除数方面两组无差异。
  • 体质指数对示踪时长无影响(p=.353)。

临床怎么用

  • 作者根据初步经验认为,两种荧光系统均可用于早期宫颈癌或子宫内膜癌的前哨淋巴结检测。
  • 作者认为PinPoint系统似可让术者更简便、更快速地识别前哨淋巴结,尤其在子宫内膜癌患者中。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY OBJECTIVE: The goal of this study was to evaluate the intraoperative and perioperative surgical outcomes of 2 different florescence systems commonly used for sentinel lymph node (SLN) mapping in women with early-stage cervical cancer or endometrial cancer. DESIGN: Case-control study (Canadian Task Force classification II-2). SETTING: The Gynecology Oncology Surgical Unit of the San Gerardo Hospital, Italy. PATIENTS: Thirty-four consecutive women with early stage-cervical cancer (stage IA-1B1) or apparent confined stage I endometrial cancer were included in the study. INTERVENTIONS: Between October 2016 and May 2017, 34 patients underwent laparoscopic surgery with SLN mapping using indocyanine green dye: 22 women were mapped with the Storz 1S system (Karl Storz Endoscopy, Tuttlingen, Germany; Group A), whereas 12 women underwent planned surgery with the Novadaq PinPoint system (Novadaq, Mississauga, Ontario, Canada; Group B). MEASUREMENT AND MAIN RESULTS: We compared the surgical and perioperative outcomes of Group A and Group B. Patients in Group B had a shorter duration of the SLN mapping time than those in Group A (p = .0003). The median number of SLNs removed was 2 (range, 0-5) in Group A and 2 (range, 1-3) in Group B (p = .501). Bilateral mapping was 77.3% in Group A and 83.3% in Group B (p = .334), respectively. No differences were recorded in terms of body mass index, length of hospital stay, type of tumor, bilateral mapping, or number of lymph nodes removed. Body mass index was found to have no impact on the duration of the mapping (p = .353). CONCLUSION: From our preliminary experience we can conclude that both fluorescence systems are valid and applicable for SLN detection in the case of early-stage cervical or endometrial cancer. The PinPoint system seems to allow surgeons easier and faster identification of the SLNs, particularly in endometrial cancer patients.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Buda A, Di Martino G, De Ponti E, et al. Laparoscopic Sentinel Node Mapping in Cervical and Endometrial Malignancies: A Case-Control Study Comparing Two Near-Infrared Fluorescence Systems. J Minim Invasive Gynecol. 2017. PMID: 28807805. doi:10.1016/j.jmig.2017.08.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。